EU panel backs Datroway for metastatic breast cancer patients
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Datroway (datopotamab deruxtecan) as ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
